Health Benefits of Dance Exercise

May 22, 2026 updated by: Dimitrios Draganidis, University of Thessaly

Effects of a 6-month Dance Exercise Intervention on Physical Performance, Metabolic and Mental Health in Pre- and Post-menopausal Women

In Greece, people of different age groups, including young children to older adults, participate in dance exercise training. Although it is well-known that regular participation in dancing is associated with benefits such as entertainment, socialization and increased physical activity, the long-term effects of dancing on metabolic and mental health as well as physical performance remain largely unknown. Therefore, the aim of this study is to investigate the effects of a 6-month dancing exercise intervention on metabolic and mental health and physical performance in premenopausal and postmenopausal women.

Study Overview

Detailed Description

Twenty premenopausal and twenty postmenopausal inactive women meeting the inclusion criteria will be randomly assigned to a Control (n=20) or an Experimental group (n=20). The Control group will maintain their habitual physical activity level without participating in any form of exercise training. The Experimental group will participate in two weekly dance exercise training sessions over a 6-month period. Each session will be performed under supervision and include a 10-min warm up (2-3 dances of very slow tempo), a 45-min main dance exercise session (~15 dances of various tempos i.e. slow, moderate and fast tempo) and a 5-min cool-down period (walking and stretching). Heart rate will be continuously monitored during each session by using heart rate monitors while the rate of perceived exertion (RPE) will be recorded at the end of each session. In addition, prior to the second dance exercise session in each week, participants' delayed onset of muscle soreness (DOMS) and wellness status (through the wellness report) will be evaluated. Prior to (Baseline) and after the intervention period (at 6 months) participants of both groups (Control and Experimental) will undergo resting blood sampling and assessment of their (i) anthropometrics, (ii) body composition, (iii) physical performance, (iv) physical activity level, (v) dietary intake, (vi) quality of life and (vii) mental health.

Study Type

Interventional

Enrollment (Estimated)

40

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

  • Name: Ioannis G Fatouros, PhD
  • Phone Number: + 30 2431047047
  • Email: ifatouros@uth.gr

Study Locations

    • Karies
      • Trikala, Karies, Greece, 42100
        • Recruiting
        • Department of Physical Education and Sport Science, University of Thessaly
        • Contact:
        • Contact:
          • Athanasios Z Jamurtas, PhD
          • Phone Number: +30 2431047054
          • Email: ajamurt@uth.gr

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Free of musculoskeletal injuries
  • Free of chronic non-communicable diseases
  • Normal menstrual cycle (for premenopausal women)
  • No recent childbirth (previous 12 months) (for premenopausal women)
  • At least 12 months since the oncet of menopause (for postmenopausal women)
  • Non smokers

Exclusion Criteria:

  • Pregnancy (for premenopausal women)
  • Contraindications to exercise training
  • Illness or other medical condition
  • Use of medication

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Control Group
Participants in this group will maintain their habitual physical activity level without participating in any form of exercise training
It will include only habitual physical activity level without participating in any form of exercise training
Experimental: Experimental Group
Participants in this group will participate in two weekly dance exercise training sessions over a 6-month period
This intervention will consist of two weekly dance exercise training sessions over a 6-month period. Each session will be performed under supervision and include a 10-min warm up (2-3 dances of very slow tempo), a 45-min main dance exercise session (~15 dances of various tempos i.e. slow, moderate and fast tempo) and a 5-min cool-down period (walking and stretching)

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in glucose concentration
Time Frame: At baseline and 6 months
Fasting glucose concentration will be determined in blood
At baseline and 6 months
Change in insulin concentration
Time Frame: At baseline and 6 months
Fasting insulin concentration will be determined in blood
At baseline and 6 months
Change in total cholesterol concentration
Time Frame: At baseline and 6 months
Total cholesterol concentration will be determined in blood
At baseline and 6 months
Change in HDL cholesterol concentration
Time Frame: At baseline and 6 months
HDL cholesterol concentration will be determined in blood
At baseline and 6 months
Change in LDL cholesterol concentration
Time Frame: At baseline and 6 months
LDL cholesterol concentration will be determined in blood
At baseline and 6 months
Change in triglycerides concentration
Time Frame: At baseline and 6 months
Triglycerides concentration will be determined in blood
At baseline and 6 months
Change in serum glutamic-oxaloacetic transaminase (SGOT/AST) concentration
Time Frame: At baseline and 6 months
SGOT concentration will be determined in blood
At baseline and 6 months
Change in alanine aminotransferase (SGPT/ALT) concentration
Time Frame: At baseline and 6 months
SGPT concentration will be determined in blood
At baseline and 6 months
Change in gamma-glutamyl transpeptidase (γ-GT) concentration
Time Frame: At baseline and 6 months
γ-GT concentration will be determined in blood
At baseline and 6 months
Change in body weight
Time Frame: At baseline and 6 months
At baseline and 6 months
Change in waist circumference
Time Frame: At baseline and 6 months
At baseline and 6 months
Change in hip circumference
Time Frame: At baseline and 6 months
At baseline and 6 months
Change in fat mass
Time Frame: At baseline and 6 months
Fat mass will be assessed by using whole-body dual-energy X-ray absorptiometry (DXA)
At baseline and 6 months
Change in body fat percentage (%)
Time Frame: At baseline and 6 months
Body fat percentage (%) will be assessed by using whole-body dual-energy X-ray absorptiometry (DXA)
At baseline and 6 months
Change in fat free mass
Time Frame: At baseline and 6 months
Fat free mass will be assessed by using whole-body dual-energy X-ray absorptiometry (DXA)
At baseline and 6 months
Change in lean body mass
Time Frame: At baseline and 6 months
Lean body mass will be assessed by using whole-body dual-energy X-ray absorptiometry (DXA)
At baseline and 6 months
Change in cardiorespiratory fitness
Time Frame: At baseline and 6 months
Cardiorespiratory fitness will be assessed using the Ebbeling single stage treadmill test
At baseline and 6 months
Change in functional performance
Time Frame: At baseline and 6 months
Functional performance will be assessed using the Short Physical Perforamnce Battery
At baseline and 6 months
Change in muscle endurance
Time Frame: At baseline and 6 months
Muscle endurance will be assessed using the push-up and curl-up testing protocols
At baseline and 6 months
Change in resting blood pressure
Time Frame: At baseline and 6 months
Resting systolic and diastolic blood pressure will be assessed using a sphygmomanometer
At baseline and 6 months
Change in quality of life
Time Frame: At baseline and 6 months
Quality of life will be evaluated using questionnaire
At baseline and 6 months
Change in vitality
Time Frame: At baseline and 6 months
Vitality will be evaluated using questionnaire
At baseline and 6 months
Change in anxiety level
Time Frame: At baseline and 6 months
Anxiety will be evaluated using questionnaire
At baseline and 6 months
Change in flourishing
Time Frame: At baseline and 6 months
Flourishing will be evaluated using questionnaire
At baseline and 6 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in dietary intake
Time Frame: At baseline and 6 months
Dietary intake will be monitored using diet recalls
At baseline and 6 months
Change in daily number of steps
Time Frame: At baseline and 6 months
Daily number of steps performed will be assessed by using accelerometers
At baseline and 6 months
Change in daily time spent in moderate-to-vigorous physical activity
Time Frame: At baseline and 6 months
The time spent in moderate-to-vigorous physical activity will be assessed by using accelerometers
At baseline and 6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Maria Bougiesi, PhD, University of Thessaly, Department of Physical Education and Sport Science

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

May 30, 2026

Primary Completion (Estimated)

November 30, 2026

Study Completion (Estimated)

December 20, 2026

Study Registration Dates

First Submitted

May 22, 2026

First Submitted That Met QC Criteria

May 22, 2026

First Posted (Actual)

May 29, 2026

Study Record Updates

Last Update Posted (Actual)

May 29, 2026

Last Update Submitted That Met QC Criteria

May 22, 2026

Last Verified

May 1, 2026

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Mental Health

Clinical Trials on No exercise training

Subscribe